DOCSLIB.ORG

C:\Temp\Copy of HB46 Enrolled (Rev

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
C:\Temp\Copy of HB46 Enrolled (Rev ENROLLED Regular Session, 2008 HOUSE BILL NO. 46 BY REPRESENTATIVE MILLS 1 AN ACT 2 To amend and reenact R.S. 40:964(Schedule I)(A), (B)(14), (C), (D)(1) and (2), and (E), 3 (Schedule II)(A)(1)(introductory paragraph) and (i) through (q), (B), 4 (C)(introductory paragraph) and (1) and (2), (D)(introductory paragraph) and (2) 5 through (4), and (E), and (Schedule III)(A)(introductory paragraph), (B), (D)(2), and 6 (E), and to enact R.S. 40:964(Schedule II)(A)(1)(r) and (6),(C)(3), (D)(5) and (6), 7 and (F) and (Schedule V)(A)(6), (C), and (D), and to repeal R.S. 40:964(Schedule 8 III)(A)(5), relative to the Controlled Dangerous Substances Law; to organize the 9 drugs in Schedules I, II, III, and V to be consistent with the federal controlled 10 substances designations; and to provide for related matters. 11 Be it enacted by the Legislature of Louisiana: 12 Section 1. R.S. 40:964(Schedule I)(A), (B)(14), (C), (D)(1) and (2), and (E), 13 (Schedule II)(A)(1)(introductory paragraph) and (i) through (q), (B), (C)(introductory 14 paragraph) and (1) and (2), (D)(introductory paragraph) and (2) through (4), and (E), and 15 (Schedule III)(A)(introductory paragraph), (B), (D)(2), and (E) are hereby amended and 16 reenacted and R.S. 40:964(Schedule II)(A)(1)(r) and (6), (C)(3), (D)(5) and (6), and (F) and 17 (Schedule V)(A)(6), (C), and (D) are hereby enacted to read as follows: 18 §964. Composition of schedules 19 Schedules I, II, III, IV, and V shall, unless and until added to pursuant to R.S. 20 40:962, consist of the following drugs or other substances, by whatever official 21 name, common or usual name, chemical name, or brand name designated: Page 1 of 15 CODING: Words in struck through type are deletions from existing law; words underscored are additions. HB NO. 46 ENROLLED 1 SCHEDULE I 2 A. Opiates. Unless specifically excepted or unless listed in another schedule, 3 any of the following opiates, including their isomers, esters, ethers, salts, or salts of 4 isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, 5 or salts is possible within the specific chemical designation: 6 *(1) Acetylmethadol Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- 7 phenethyl)-4-piperidinyl]-N-phenylacetamide) 8 *(2) Allylprodine Acetylmethadol 9 *(3) Alphacetylmethadol Allylprodine 10 *(4) Alphameprodine Alphacetylmethadol (except levo-alphacetylmethadol, 11 also known as levomethadyl acetate, or LAAM) 12 *(5) Alphamethadol Alphameprodine 13 *(6) Benzethidine Alphamethadol 14 *(7) Betacetylmethadol Alpha-methylfentanyl (N-[1-(alpha-methyl-beta- 15 phenyl) ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- 16 propanilido) piperidine) 17 *(8) Betameprodine Alpha-methylthiofentanyl (N-[1-methyl-2-(2- 18 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) 19 *(9) Betamethadol Benzethidine 20 *(10) Betaprodine Betacetylmethadol 21 *(11) Clonitazene Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- 22 piperidinyl]-N-phenylpropanamide) 23 *(12) Dextromoramide Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- 24 phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) 25 *(13) Dextrorphan Betameprodine 26 *(14) Diampromide Betamethadol 27 *(15) Diethylthiambutene Betaprodine 28 *(16) Difenoxin Clonitazene 29 *(17) Dimenoxadol Dextromoramide 30 *(18) Dimepheptanol Diampromide Page 2 of 15 CODING: Words in struck through type are deletions from existing law; words underscored are additions. HB NO. 46 ENROLLED 1 *(19) Dimethylthiambutene Diethylthiambutene 2 *(20) Dioxaphetyl butyrate Difenoxin 3 *(21) Dipipanone Dimenoxadol 4 *(22) Ethylmethylthiambutene Dimepheptanol 5 *(23) Etonitazene Dimethylthiambutene 6 *(24) Etoxeridine Dioxaphetyl butyrate 7 *(25) Furethidine Dipipanone 8 *(26) Hydroxypethidine Ethylmethylthiambutene 9 *(27) Ketobemidone Etonitazene 10 *(28) Levomoramide Etoxeridine 11 *(29) Levophenacylmorphan Furethidine 12 *(30) Morpheridine Hydroxypethidine 13 *(31) Noracymethadol Ketobemidone 14 *(32) Norlevorphanol Levomoramide 15 *(33) Normethadone Levophenacylmorphan 16 *(34) Norpipanone 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- 17 piperidyl]-N-phenylpropanamide) 18 *(35) Phenadoxone 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4- 19 piperidinyl]-N-phenylpropanamide) 20 *(36) Phenampromide Morpheridine 21 *(37) Phenomorphan MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 22 *(38) Phenoperidine Noracymethadol 23 *(39) Piritramide Norlevorphanol 24 *(40) Proheptazine Normethadone 25 *(41) Properidine Norpipanone 26 *(42) Propiram Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)- 27 4-piperidinyl] propanamide) 28 *(43) Racemoramide PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperdine) 29 *(44) Trimeperidine Phenadoxone 30 *(45) Phenampromide Page 3 of 15 CODING: Words in struck through type are deletions from existing law; words underscored are additions. HB NO. 46 ENROLLED 1 *(46) Phenomorphan 2 *(47) Phenoperidine 3 *(48) Piritramide 4 *(49) Proheptazine 5 *(50) Properidine 6 *(51) Propiram 7 *(52) Racemoramide 8 *(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- 9 propanamide) 10 *(54) Tilidine 11 *(55) Trimeperidine 12 B. Opium derivatives. Unless specifically excepted or unless listed in 13 another schedule, any of the following opium derivatives, its salts, isomers, and salts 14 of isomers whenever the existence of such salts, isomers, and salts of isomers is 15 possible within the specific chemical designation: 16 * * * 17 *(14) Methylhydromorphine Methyldihydromorphine 18 * * * 19 C. Hallucinogenic substances. Unless specifically excepted or unless listed 20 in another schedule, any material, compound, mixture, or preparation, which 21 contains any quantity of the following hallucinogenic substances, or which contains 22 any of their salts, isomers, or salts of isomers, whenever the existence of such salts, 23 isomers, or salts of isomers is possible within the specific chemical designation, for 24 purposes of this Paragraph only, the term "isomer" includes the optical, position, and 25 geometric isomers: 26 (1) 3,4-methylenedioxy amphetamine Alpha-ethyltryptamine 27 (2) 5-methoxy-3,4-methylenedioxy amphetamine 4-bromo-2,5- 28 dimethoxyamphetamine 29 (3) 3,4,5-trimethoxy amphetamine 4-bromo-2,5-dimethoxyphenethylamine 30 (4) Bufotenine 2,5-dimethoxyamphetamine Page 4 of 15 CODING: Words in struck through type are deletions from existing law; words underscored are additions. HB NO. 46 ENROLLED 1 (5) Diethyltryptamine 2,5-dimethoxy-4-ethylamphetamine 2 (6) Dimethyltryptamine 4-methoxyamphetamine 3 (7) 4-methyl-2,5-dimethoxyamphetamine5-methoxy-3,4- 4 methylenedioxyamphetamine 5 (8) Ibogaine 4-methyl-2,5-dimethoxyamphetamine 6 (9) Lysergic acid diethylamide 3,4-methylenedioxyamphetamine 7 (10) Mescaline 3,4-methylenedioxymethamphetamine (MDMA) 8 (11) Peyote 3,4-methylenedioxy-N-ethylamphetamine 9 (12) N-ethyl-3-piperidyl benzilate N-hydroxy-3,4- 10 methylenedioxyamphetamine 11 (13) N-methyl-3-piperidyl benzilate 3,4,5-trimethoxy amphetamine 12 (14) Psilocybin Bufotenine 13 (15) Psilocyn Diethyltryptamine 14 (16) 2,5-dimethoxyamphetamine Dimethyltryptamine 15 (17) 4-bromo-2,5-dimethoxyamphetamine Ibogaine 16 (18) 4-methoxyamphetamine Lysergic acid diethylamide 17 (19) 1-[1-(2-thienyl) cyclohexyl] piperidine Marihuana 18 (20) Cyclohexamine Mescaline 19 (21) 1-piperidinocyclohexanecarbonitrile Parahexyl, also known as Synhexyl 20 (22) Marijuana, tetrahydrocannabinols, or chemical derivatives of 21 tetrahydrocannabinols Peyote 22 (23) 3,4-methylenedioxymethamphetamine (MDMA) N-ethyl-3-piperidyl 23 benzilate 24 (24) N-ethyl-3,4-methylenedioxyamphetamineN-methyl-3-piperidyl benzilate 25 (25) N-hydroxy methylenedioxyamphetamine Psilocybin 26 (26) Psilocyn 27 (27) Tetrahydrocannabinols, including synthetic equivalents and derivatives 28 (28) Ethylamine analog of phencyclidine 29 (29) Pyrrolidine analog of phencyclidine Page 5 of 15 CODING: Words in struck through type are deletions from existing law; words underscored are additions. HB NO. 46 ENROLLED 1 (30) Thiophene analog of phencyclidine 2 (31) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine 3 D. Depressants. Unless specifically excepted or unless listed in another 4 schedule, any material, compound, mixture, or preparation which contains any 5 quantity of the following substances having a depressant effect on the central 6 nervous system, including its salts, isomers, and salts of isomers whenever the 7 existence of such salts, isomers, and salts of isomers is possible within the specific 8 chemical designation: 9 (1) Mecloqualone Gamma-hydroxybutyric acid (GHB) 10 (2) Phencyclidine Mecloqualone 11 * * * 12 E. Stimulants. Unless specifically excepted or unless listed in another 13 schedule, any material, compound, mixture, or preparation which contains any 14 quantity of the following substances having a stimulant effect on the central nervous 15 system including its salts, isomers, and salts of isomers whenever the existence of 16 such salts, isomers, and salts of isomers is possible within the specific chemical 17 designation: 18 (1) N-ethylamphetamine Aminorex 19 (2) Fenethylline Cathinone 20 (3) Fenethylline 21 (4) Methcathinone 22 (5) (±)cis-4-methylaminorex 23 (6) N-ethylamphetamine 24 (7) N,N-dimethylamphetamine 25 SCHEDULE II 26 A. Substances of vegetable origin or chemical synthesis. Unless specifically 27 excepted or unless listed in another schedule, any of the following substances 28 whether produced directly or indirectly by extraction from substances of vegetable 29 origin, or independently by
Load more

Recommended publications
  • Screening/Spot Test of Narcotics
    Indian Journal of Forensic and Community Medicine 2020;7(4):160–165 Content available at: https://www.ipinnovative.com/open-access-journals Indian Journal of Forensic and Community Medicine Journal homepage: https://www.ipinnovative.com/journals/IJFCM Review Article Screening/spot test of narcotics A K Jaiswal1,*, Kamna Sharma2, Rohit Kanojia3, Sally Lukose4 1Dept. of Forensic Medicine & Toxicology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 2Galgotias University, Greater Noida, Uttar Pradesh, India 3Dept. of Chemistry, University of Delhi, New Delhi, India 4CTM-IRTE, Faridabad, Haryana, India ARTICLEINFO ABSTRACT Article history: Narcotics are the substances used to treat moderate to severe pain. They could be natural like opiates such Received 25-11-2020 as morphine, codeine etc., synthetic like fentanyl, methadone etc., and semi-synthetic like oxycodone, Accepted 02-12-2020 hydrocodone etc. These drugs act as pain relievers, induces the state of stupor or sleep, and increase Available online 08-01-2021 the physical dependence on them. In forensic autopsy case, the forensic pathologist may require a complete toxicological investigation for different poisons including stimulants. In India, Forensic Science Laboratories run by Government under the Home ministry usually carry out this. The samples must be Keywords: analysed by the forensic toxicologist/chemists/scientist. This article deals with the screening/spot test for Narcotics narcotics. It attempts to simplify the standard procedures in a step-wise manner, which can be of handy Screening reference for the forensic toxicologist. Spot test Drugs © This is an open access article distributed under the terms of the Creative Commons Attribution Opioids etc License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • 2020 Kansas Statutes
    2020 Kansas Statutes 65-4105. Substances included in schedule I. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it. (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide) 9815 (3) Acetylmethadol 9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811 (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551 (6) Allylprodine 9602 (7) Alphacetylmethadol 9603(except levo-alphacetylmethadol also known as levo- alpha-acetylmethadol, levomethadyl acetate or LAAM) (8) Alphameprodine 9604 (9) Alphamethadol 9605 (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814 (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide) 9832 (12) Benzethidine 9606 (13) Betacetylmethadol 9607 (14) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) 9830 (15) Beta-hydroxy-3-methylfentanyl (other
    [Show full text]
  • Effects of Prophylactic Ketamine and Pethidine to Control Postanesthetic Shivering: a Comparative Study
    Biomedical Research and Therapy, 5(12):2898-2903 Original Research Effects of prophylactic ketamine and pethidine to control postanesthetic shivering: A comparative study Masoum Khoshfetrat1, Ali Rosom Jalali2, Gholamreza Komeili3, Aliakbar Keykha4;∗ ABSTRACT Background: Shivering is an undesirable complication following general anesthesia and spinal anesthesia, whose early control can reduce postoperative metabolic and respiratory complications. Therefore, this study aims to compare the effects of prophylactic injection of ketamine and pethi- dine on postoperative shivering.Methods: This double-blind clinical trial was performed on 105 patients with short-term orthopedic and ENT surgery. The patients were randomly divided into three groups; 20 minutes before the end of the surgery, 0.4 mg/kg of pethidine was injected to the first group, 0.5 mg/kg of ketamine was injected to the second group, and normal saline was injected to the third group. After the surgery, the tympanic membrane temperature was measured at 0, 10, 20, and 30 minutes. The shivering was also measured by a four-point grading from zero (no shiv- ering) to four (severe shivering). Data were analyzed by one-way ANOVA, Kruskal Wallis, Chi-square 1Doctor of Medicine (MD), Fellow of and Pearson correlation. Results: The mean age of patients was 35.811.45 years in the ketamine Critical Care Medicine (FCCM), group, 34.811.64 years in the normal saline group, and 33.1110.5 years in the pethidine group. Department of Anesthesiology and The one-way ANOVA showed no significant difference in the mean age between the three groups Critical Care, Khatam-Al-Anbiya (P=0.645).
    [Show full text]
  • The In¯Uence of Medication on Erectile Function
    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
    [Show full text]
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • Pre - PA Allowance Age 12 Years of Age Or Older – Ultracet (Tramadol and Acetaminophen) and Codeine/APAP Products
    OPIOID IR COMBO DRUGS Apadaz* (benzhydrocodone-acetaminophen), Codeine-acetaminophen, Dvorah* (dihydrocodeine-caffeine-acetaminophen*), Hydrocodone-acetaminophen, Hydrocodone- acetaminophen solution 10-325mg*, Hydrocodone-ibuprofen, Nalocet* (oxycodone- acetaminophen*), Oxycodone-acetaminophen, Oxycodone-aspirin, Oxycodone-ibuprofen, Primlev*/Prolate* (oxycodone-acetaminophen*), Tramadol-acetaminophen, Trezix (dihydrocodeine-caffeine-acetaminophen) *Prior authorization for certain non-covered formulations applies only to formulary exceptions Pre - PA Allowance Age 12 years of age or older – Ultracet (tramadol and acetaminophen) and Codeine/APAP products Quantity Patients 18 years or older will be able to fill the Pre-PA Allowance after they have filled an initial 7 day supply of IR opioid therapy or if they have been on IR or ER opioid therapy in the last 180 days Patients age 17 and under will require a PA after they have filled a 3 day supply of the Pre- PA Allowance Patients with opioid addiction treatment or methadone in the last 30 days will not be eligible for Pre-PA Allowance Immediate Release Tablets or Capsules ≤ 50 MME/day Medication Strength Quantity Limit Codeine/APAP soln 120-12 mg/5 mL Hydrocodone/APAP soln 7.5/325 mg/15 mL 5400 mL per 90 days Hydrocodone/APAP elixir 10/300 mg/15 mL Oxycodone/APAP soln 5-325 mg/5 mL 3000 mL per 90 days Hydrocodone/ibuprofen 5/200 mg, 7.5/200 mg, 10/200 mg 270 units per 90 days Oxycodone/ibuprofen 5/400 mg Oxycodone/APAP 10/325 mg Codeine/APAP 60/300 mg Hydrocodone/APAP 7.5/300 mg, 7.5/325
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • 1 Impact of Opioid Agonists on Mental Health in Substitution
    Impact of opioid agonists on mental health in substitution treatment for opioid use disorder: A systematic review and Bayesian network meta-analysis of randomized clinical trials Supplementary Table 1_ Specific search strategy for each database The following general combination of search terms, Boolean operators, and search fields were used where “*” means that any extension of that word would be considered: Title field [opium OR opiate* OR opioid OR heroin OR medication assisted OR substitution treatment OR maintenance treatment OR methadone OR levomethadone OR buprenorphine OR suboxone OR (morphine AND slow) OR diamorphine OR diacetylmorphine OR dihydrocodeine OR hydromorphone OR opium tincture OR tincture of opium OR methadol OR methadyl OR levomethadyl] AND Title/Abstract field [trial* OR random* OR placebo] AND All fields [depress* OR anxiety OR mental] Wherever this exact combination was not possible, a more inclusive version of the search strategy was considered. Database Search Strategy Ovid for EBM Reviews - Cochrane Central Register of (opium or opiate$ or opioid or heroin or medication Controlled Trials August 2018; Embase 1974 to assisted or substitution treatment or maintenance September 07, 2018; MEDLINE(R) and Epub Ahead treatment or methadone or levomethadone or of Print, In-Process & Other Non-Indexed Citations buprenorphine or suboxone or (morphine and slow) or and Daily 1946 to September 07, 2018 diamorphine or diacetylmorphine or dihydrocodeine or hydromorphone or opium tincture or tincture of opium or methadol or methadyl
    [Show full text]
  • Chapter 329 [New] Uniform Controlled Substances Act
    CHAPTER 329 [NEW] UNIFORM CONTROLLED SUBSTANCES ACT Part I. General Provisions Section 329-1 Definitions 329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment 329-3 Annual report 329-4 Duties of the commission Part II. Standards and Schedules 329-11 Authority to schedule controlled substances 329-12 Nomenclature 329-13 Schedule I tests 329-14 Schedule I 329-15 Schedule II tests 329-16 Schedule II 329-17 Schedule III Tests 329-18 Schedule III 329-19 Schedule IV tests 329-20 Schedule IV 329-21 Schedule V tests 329-22 Schedule V 329-23 Republishing and distribution of schedules Part III. Regulation of Manufacture, Distribution, Prescription, and Dispensing of Controlled Substances 329-31 Rules 329-31.5 Clinics 329-32 Registration requirements 329-33 Registration 329-34 Revocation and suspension of registration 329-35 Order to show cause 329-36 Records of registrants 329-37 Filing requirements 329-38 Prescriptions 329-39 Labels 329-40 Methadone treatment programs Part IV. Offenses and Penalties 329-41 Prohibited acts B-penalties 329-42 Prohibited acts C-penalties 329-43 Penalties under other laws 329-43.5 Prohibited acts related to drug paraphernalia Amended 0612 1 329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs 329-45 Repealed 329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions 329-49 Administrative penalties 329-50 Injunctive relief Part V. Enforcement and Administrative Provisions 329-51 Powers of enforcement personnel 329-52 Administrative inspections 329-53 Injunctions 329-54 Cooperative arrangements and confidentiality 329-55 Forfeitures 329-56 Burden of proof; liabilities 329-57 Judicial review 329-58 Education and research 329-59 Controlled substance registration revolving fund; established Part VI.
    [Show full text]
  • Post- Operative Pain- Relief
    PPoosstt-- OOppeerraattiivvee PPaaiinn-- RReelliieeff • Pain is often the patient’s presenting symptom. It can provide useful clinical information and it is your responsibility to use this information to help the patient and alleviate suffering. • Manage pain wherever you see patients (emergency, operating room and on the ward) and anticipate their needs for pain management after surgery and discharge. • Do not unnecessarily delay the treatment of pain; for example, do not transport a patient without analgesia simply so that the next practitioner can appreciate how much pain the person is experiencing. • Pain management is our job. Pain Management and Techniques • Effective analgesia is an essential part of postoperative management. • Important injectable drugs for pain are the opiate analgesics. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as diclofenac (1 mg/kg) and ibuprofen can also be given orally and rectally, as can paracetamol (15 mg/kg). • There are three situations where an opiate might be given: pre- operatively, intra-operatively, post-operatively. •• Opiate premedication is rarely indicated, although an injured patient in pain may have been given an opiate before coming to the operating room. • Opiates given pre- or intraoperatively have important effects in the postoperative period since there may be delayed recovery and respiratory depression, even necessitating mechanical ventilation. (continued to next page) PPoosstt-- OOppeerraattiivvee PPaaiinn-- RReelliieeff ((ccoonnttiiinnuueedd)) • Short acting opiate fentanyl is used intra-operatively to avoid this prolonged effect. • Naloxone antagonizes (reverses) all opiates, but its effect quickly wears off. • Commonly available inexpensive opiates are pethidine and morphine. • Morphine has about ten times the potency and a longer duration of action than pethidine.
    [Show full text]